Title : Inhibition of effector B cells by ibrutinib in systemic sclerosis.

Pub. Date : 2020 Mar 30

PMID : 32228672






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Ibrutinib was able to reduce the production of the profibrotic hallmark cytokines IL-6 and TNF-alpha mainly from the effector B cell population in patients with SSc. ibrutinib tumor necrosis factor Homo sapiens